Showing results (541-550 of 790) with videos related to

Sort By:
Pageof 79
Nature|June 20, 2023
A binary pulsar in a 53-minute orbitZ Pan, J G Lu, P Jiang, et al.
Scientific Reports|September 3, 2015
Whole genome and transcriptome sequencing of matched primary and peritoneal metastatic gastric carcinomaJ Zhang, J Y Huang, Y N Chen, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|March 27, 2025
[Expert consensus: reducing free-sugar for caries prevention]X J Zeng, X N Liu, M Liu, et al.
Genome Research|October 24, 2000
Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cellsQ H Zhang, M Ye, X Y Wu, et al.
The Journal of Urology|April 7, 2020
Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate CancerJ Woo, S Santasusagna, J Banks, et al.
Nature Human Behaviour|April 27, 2019
Regional ambient temperature is associated with human personalityWenqi Wei, Jackson G Lu, Adam D Galinsky, et al.
European Journal of Cancer Care|April 11, 2017
Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III studyL Q Yang, X C Sun, S K Qin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 12, 2018
[Qualitative pathological assessment of liver fibrosis regression after antiviral therapy in patients with chronic hepatitis B]Y M Sun, J L Zhou, L Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liverX R Xu, J Huang, Z G Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 16, 2021
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆X H Wu, J Q Zhu, R T Yin, et al.
Pageof 79